You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
RS 100329 hydrochloride
Biological Activity for RS 100329 hydrochloride
RS 100329 hydrochloride is a subtype-selective α1A-adrenoceptor antagonist (pKi = 9.6 for human cloned α1A receptors). Displays 126- and 50-fold selectivity over human α1B and α1D receptors respectively. Active in vivo.
Sold with the permission of Roche Bioscience
Technical Data for RS 100329 hydrochloride
|Storage||Store at RT|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solubility Data for RS 100329 hydrochloride
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions for RS 100329 hydrochloride
The following data is based on the product molecular weight 462.89. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||2.16 mL||10.8 mL||21.6 mL|
|5 mM||0.43 mL||2.16 mL||4.32 mL|
|10 mM||0.22 mL||1.08 mL||2.16 mL|
|50 mM||0.04 mL||0.22 mL||0.43 mL|
Product Datasheets for RS 100329 hydrochloride
References for RS 100329 hydrochloride
References are publications that support the biological activity of the product.
Conley et al (2001) The role of α1-adrenoceptors and 5-HT1A receptors in the control of the micturition reflex in male anaesthetized rats. Br.J.Pharmacol. 133 61 PMID: 11325795
Shannon Kava et al (1998) α1L-Adrenoceptor mediation of smooth muscle contraction in rabbit bladder neck: a model for lower urinary tract tissues of man. Br.J.Pharmacol. 123 1359 PMID: 9579731
Williams et al (1999) In vitro α1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel α1A-adrenoceptor selective antagonists. Br.J.Pharmacol. 127 252 PMID: 10369480
If you know of a relevant reference for RS 100329 hydrochloride, please let us know.
View Related Products by Product Action
Keywords: RS 100329 hydrochloride, RS 100329 hydrochloride supplier, Potent, subtype, selective, α1A-adrenoceptor, alpha1A-adrenoceptor, a1a-adrenoceptor, antagonists, α1a-adrenergic, alpha1a-adrenergic, a1a-adrenergic, receptors, RS100329, hydrochloride, Adrenergic, Alpha-1, Receptors, 1325, Tocris Bioscience
3 Citations for RS 100329 hydrochloride
Citations are publications that use Tocris products. Selected citations for RS 100329 hydrochloride include:
Cleary et al (2004) Sympathectomy reveals alpha 1A- and alpha 1D-adrenoceptor components to contractions to noradrenaline in rat vas deferens. Br J Pharmacol 143 745 PMID: 15451776
Zacharia et al (2013) High vascular tone of mouse femoral arteries in vivo is determined by sympathetic nerve activity via α1A- and α1D-adrenoceptor subtypes. PLoS One 8 e65969 PMID: 23776582
Ishii and Sugimura (2015) Identification of a new pharmacological activity of the phenylpiperazine derivative naftopidil: tubulin-binding drug. Front Cell Neurosci 8 42618 PMID: 25584077
Do you know of a great paper that uses RS 100329 hydrochloride from Tocris? Please let us know.
Reviews for RS 100329 hydrochloride
There are currently no reviews for this product. Be the first to review RS 100329 hydrochloride and earn rewards!
Have you used RS 100329 hydrochloride?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.